February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla: Capturing Opportunity in a Contrarian Market
Microsoft: Resilient Amid Sell-Off, 'Buy' Stance Reaffirmed
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Mirati Therapeutics (MRTX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: March 17, 2025 (09:43)
Sector: HealthcareThe share price of Mirati Therapeutics, Inc. (MRTX) now
Are you interested in Mirati Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mirati Therapeutics stock price in 2025, 2026, 2027. How much will one Mirati Therapeutics share be worth in 2025 - 2027?
When should I take profit in Mirati Therapeutics stock? When should I record a loss on Mirati Therapeutics stock? What are analysts' forecasts for Mirati Therapeutics stock? What is the future of Mirati Therapeutics stock? We forecast Mirati Therapeutics stock performance using neural networks based on historical data on Mirati Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Mirati Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Mirati Therapeutics shares. This happens once a day.
Historical and forecast chart of Mirati Therapeutics stock
The chart below shows the historical price of Mirati Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Mirati Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is focused on developing a pipeline of targeted cancer drugs. The company is developing candidate products to combat genetic and immunological cancer promoters. Its clinical programs consist of two candidate products: MRTX849, a Kirsten rat sarcoma inhibitor (KRAS) G12C, and Sitravatinib, a multi-kinase inhibitor. His KRAS inhibitor program is focused on the discovery and development of small molecule compounds that target KRAS G12C and G12D. MRTX849 is designed to inhibit the KRAS G12C mutations that are present in patients with non-small cell lung cancer (NSCLC), adenocarcinoma, colorectal cancer (CRC), pancreatic cancer, and several other intractable cancers. Sitravatinib is a spectrally selective kinase inhibitor designed to inhibit receptor tyrosine kinases (RTKs) including TAM family receptors (TYRO3, Axl, Mer), split family receptors (VEGFR2, KIT) and RET.
Mirati Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar 19 | 60.45 | 59.72 | 61.77 | 3.43 |
| Mar 20 | 59.92 | 59.13 | 60.68 | 2.61 |
| Mar 21 | 60.44 | 59.65 | 61.77 | 3.56 |
| Mar 22 | 60.39 | 59.90 | 60.91 | 1.69 |
| Mar 23 | 59.61 | 58.72 | 60.18 | 2.50 |
| Mar 24 | 60.22 | 59.50 | 61.09 | 2.67 |
| Mar 25 | 60.33 | 59.28 | 61.48 | 3.72 |
| Mar 26 | 60.96 | 59.70 | 62.37 | 4.47 |
| Mar 27 | 61.95 | 61.56 | 63.19 | 2.66 |
| Mar 28 | 60.72 | 59.86 | 61.19 | 2.22 |
| Mar 29 | 60.87 | 60.15 | 61.29 | 1.88 |
| Mar 30 | 61.25 | 60.17 | 62.15 | 3.30 |
| Mar 31 | 61.16 | 59.98 | 62.19 | 3.67 |
| Apr 01 | 61.62 | 60.66 | 62.74 | 3.44 |
| Apr 02 | 61.49 | 60.53 | 62.74 | 3.66 |
| Apr 03 | 60.77 | 59.53 | 61.19 | 2.79 |
| Apr 04 | 62.50 | 61.60 | 63.57 | 3.20 |
| Apr 05 | 63.78 | 62.84 | 64.33 | 2.38 |
| Apr 06 | 62.01 | 60.92 | 62.65 | 2.84 |
| Apr 07 | 61.79 | 61.20 | 63.13 | 3.15 |
| Apr 08 | 61.03 | 59.66 | 61.58 | 3.22 |
| Apr 09 | 59.60 | 58.80 | 60.57 | 3.01 |
| Apr 10 | 59.41 | 58.21 | 60.42 | 3.80 |
| Apr 11 | 59.00 | 57.95 | 60.15 | 3.79 |
| Apr 12 | 59.90 | 59.05 | 60.69 | 2.77 |
| Apr 13 | 60.73 | 60.02 | 62.02 | 3.34 |
| Apr 14 | 59.45 | 58.33 | 60.29 | 3.36 |
| Apr 15 | 57.93 | 57.27 | 58.96 | 2.94 |
| Apr 16 | 56.93 | 56.29 | 57.78 | 2.64 |
| Apr 17 | 55.36 | 54.62 | 55.77 | 2.10 |
Mirati Therapeutics Daily Price Targets
Mirati Therapeutics Stock Forecast 03-19-2025.
Forecast target price for 03-19-2025: $60.45.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.317%.
Pessimistic target level: 59.72
Optimistic target level: 61.77
Mirati Therapeutics Stock Forecast 03-20-2025.
Forecast target price for 03-20-2025: $59.92.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.548%.
Pessimistic target level: 59.13
Optimistic target level: 60.68
Mirati Therapeutics Stock Forecast 03-21-2025.
Forecast target price for 03-21-2025: $60.44.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.435%.
Pessimistic target level: 59.65
Optimistic target level: 61.77
Mirati Therapeutics Stock Forecast 03-22-2025.
Forecast target price for 03-22-2025: $60.39.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 1.665%.
Pessimistic target level: 59.90
Optimistic target level: 60.91
Mirati Therapeutics Stock Forecast 03-23-2025.
Forecast target price for 03-23-2025: $59.61.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.437%.
Pessimistic target level: 58.72
Optimistic target level: 60.18
Mirati Therapeutics Stock Forecast 03-24-2025.
Forecast target price for 03-24-2025: $60.22.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.603%.
Pessimistic target level: 59.50
Optimistic target level: 61.09
MRTX (MRTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr. | 58.00 | 52.25 | 60.43 | 13.53 |
| May. | 61.74 | 57.85 | 67.11 | 13.80 |
| Jun. | 62.20 | 60.15 | 68.73 | 12.49 |
| Jul. | 62.01 | 56.90 | 63.87 | 10.92 |
| Aug. | 64.99 | 60.99 | 71.72 | 14.95 |
| Sep. | 66.06 | 60.81 | 69.13 | 12.04 |
| Oct. | 62.69 | 58.55 | 66.08 | 11.39 |
| Nov. | 61.94 | 54.60 | 66.31 | 17.66 |
| Dec. | 58.32 | 53.94 | 62.25 | 13.35 |
Mirati Therapeutics forecast for this year
Mirati Therapeutics Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $57.9956. Pessimistic: $52.25. Optimistic: $60.43
Mirati Therapeutics Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $61.7363. Pessimistic: $57.85. Optimistic: $67.11
Mirati Therapeutics Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $62.1993. Pessimistic: $60.15. Optimistic: $68.73
Mirati Therapeutics Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $62.0127. Pessimistic: $56.90. Optimistic: $63.87
Mirati Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $64.9893. Pessimistic: $60.99. Optimistic: $71.72
Mirati Therapeutics Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $66.0617. Pessimistic: $60.81. Optimistic: $69.13
Mirati Therapeutics Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $62.6925. Pessimistic: $58.55. Optimistic: $66.08
Mirati Therapeutics Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $61.9402. Pessimistic: $54.60. Optimistic: $66.31
Mirati Therapeutics Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $58.3167. Pessimistic: $53.94. Optimistic: $62.25
Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 57.18 | 53.23 | 60.87 | 12.54 |
| Feb | 57.18 | 55.04 | 59.84 | 8.03 |
| Mar | 59.84 | 57.59 | 64.86 | 11.21 |
| Apr | 60.65 | 56.10 | 66.65 | 15.83 |
| May | 67.01 | 63.80 | 70.83 | 9.93 |
| Jun | 76.16 | 69.65 | 80.73 | 13.73 |
| Jul | 85.42 | 77.86 | 94.51 | 17.62 |
| Aug | 82.60 | 74.30 | 85.20 | 12.80 |
| Sep | 82.10 | 75.33 | 85.30 | 11.69 |
| Oct | 92.08 | 84.20 | 99.67 | 15.52 |
| Nov | 79.78 | 77.03 | 86.73 | 11.18 |
| Dec | 75.24 | 71.96 | 77.72 | 7.41 |
Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 71.06 | 67.54 | 75.86 | 10.96 |
| Feb | 63.28 | 59.96 | 65.84 | 8.94 |
| Mar | 64.61 | 57.82 | 70.33 | 17.78 |
| Apr | 73.43 | 67.26 | 79.26 | 15.15 |
| May | 72.55 | 68.63 | 77.23 | 11.13 |
| Jun | 68.19 | 60.21 | 70.44 | 14.52 |
| Jul | 63.28 | 58.25 | 68.50 | 14.97 |
| Aug | 54.74 | 52.28 | 59.67 | 12.39 |
| Sep | 51.70 | 46.66 | 55.50 | 15.93 |
| Oct | 54.80 | 52.42 | 58.83 | 10.90 |
| Nov | 57.76 | 54.73 | 62.36 | 12.23 |
| Dec | 61.06 | 56.20 | 63.44 | 11.41 |
Mirati Therapeutics information and performance
N/A
Market capitalization of the Mirati Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MRTX shares in the company outstanding by the market price of one share.
EBITDA of Mirati Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Mirati Therapeutics Stock)
Should I Buy Mirati Therapeutics Shares in 2025 year?
Does Mirati Therapeutics pay dividends?
Which economic sector do Mirati Therapeutics's shares belong to?
Which other securities belong to the same sector as Mirati Therapeutics's shares?
